Elimination of bitter, disgusting tastes of drugs and foods by cyclodextrins.

The bitter taste of drugs, food components, and any other substances which get in the mouth as dissolved in an aqueous solution, or in the saliva, can be strongly reduced or fully eliminated, if the bitter component forms an inclusion complex with an appropriate cyclodextrin (CD). The value of the complex association constant (determined by the structure of the bitter 'guest' molecule and the size and eventual substitution of the 'host' CD molecule), the temperature and the host/guest ratio determine the extent of complexation of the guest molecule (percentage of complexation) at the equilibrium. The K(ass) for most drug/CD complexes at 36 degrees C buccal cavity temperature is between 10(2) and 10(4) mol-1. If the unit dose (of a sublingual or chewing tablet, chewing gum) with a bitter drug (molecular weight of about 150, forming a 1:1 complex with betaCD) is approximately 10mg then the betaCD can be taken in a 5- or even 10-fold molar excess. Under such conditions more than 99% of the bitter drug is complexed, and because complexed molecules cannot react with the taste buds in the buccal cavity no bitter taste is perceived. Frequently, preparation of the drug/CD complex is not necessary, because the betaCD is present in a large excess, dissolved very quickly in the saliva and results in a saturated CD solution. Therefore, the complexation of the bitter drug is completed very rapidly. Only dissolved substances have taste and only CD complexable drug molecules can become debittered by CDs. Bitter, astringent components of foods (e.g. soya), beverages (e.g. naringin in citrus fruit juice, or chlorogenic acid and polyphenols in coffee) cigarette smoke (nicotine) also can be complexed and their taste reduced or fully eliminated.

[1]  J. Toda,et al.  INTERACTION OF CYCLODEXTRINS WITH TASTE SUBSTANCES , 1981 .

[2]  Friedrich Cramer,et al.  A process for the preparation of inclusion compounds of physiologically active organic compounds , 1951 .

[3]  T. Imai,et al.  Improvement of oral bioavailability of fenbufen by cyclodextrin complexations. , 1992, Acta pharmaceutica Nordica.

[4]  T. Imai,et al.  [Stabilization and reduction of irritant taste of anti-inflammatory drug pirprofen by beta-cyclodextrin complexation]. , 1984, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[5]  T. Noguchi,et al.  Biopharmaceutical study of inclusion complexes. I. Pharmaceutical advantages of cyclodextrin complexes of bencyclane fumarate. , 1983, Chemical & pharmaceutical bulletin.

[6]  J. Toda,et al.  Bitterness Reduction of Naringin and Limonin by β-Cyclodextrin , 1982 .

[7]  F. Cramer,et al.  Inclusion compounds of cyclodextrins , 2005, Naturwissenschaften.

[8]  Charles W. Wilson,et al.  Improved flavor of navel orange and grapefruit juices by removal of bitter components with .beta.-cyclodextrin polymer , 1984 .

[9]  S. Neya,et al.  Reduction of the Bitter Taste Intensity of Propantheline Bromide by Cyclodextrins As Predicted by Surface Tension Measurements , 1996 .

[10]  J. Szejtli,et al.  Bitterness Reduction with Beta-Cyclodextrin , 1988 .

[11]  C. W. Wilson,et al.  Reduction of Grapefruit Bitter Components in a Fluidized β‐Cyclodextrin Polymer Bed , 1988 .

[12]  G. Charalambous,et al.  The Quality of foods and beverages : chemistry and technology , 1981 .

[13]  R. Kawaguchi,et al.  Ultraviolet spectroscopic estimation of microenvironments and bitter tastes of oxyphenonium bromide in cyclodextrin solutions. , 1999, Journal of pharmaceutical sciences.

[14]  K. Uekama,et al.  Improvement of some pharmaceutical properties of clofibrate by cyclodextrin complexation. , 1983, Pharmaceutica acta Helvetiae.

[15]  H. Bundgaard,et al.  Formation, bioavailability and organoleptic properties of an inclusion complex of femoxetine with β-cyclodextrin , 1984 .

[16]  C. W. Wilson,et al.  Debittering Citrus Juices with β‐Cyclodextrin Polymer , 1983 .